Hockel 2019

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

2/27/23, 1:37 AM Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from

esults from a single-centre, prospective, o…

An official website of the United States government


Here's how you know

full text links

Lancet Oncol. 2019 Sep;20(9):1316-1326. doi: 10.1016/S1470-2045(19)30389-4. Epub 2019 Aug 2.

Surgical resection based on ontogenetic cancer field


theory for cervical cancer: mature results from a
single-centre, prospective, observational, cohort
study
Michael Höckel  1 , Benjamin Wolf  2 , Katja Schmidt  3 , Meinhard Mende  4 , Bahriye Aktas  2 , 
Rainer Kimmig  5 , Nadja Dornhöfer  2 , Lars-Christian Horn  6

Affiliations
PMID: 31383547 DOI: 10.1016/S1470-2045(19)30389-4

Abstract
Background: Previous findings from our centre suggest that carcinoma of the cervix propagates
within ontogenetic cancer fields, tissue compartments defined by staged morphogenesis. We aimed
to determine whether surgical treatment that accounts for stage-associated, ontogenetic cancer fields
and their associated lymphoid tissues results in locoregional tumour control without the need for
adjuvant radiotherapy.

Methods: We did the final clinical and histopathological evaluation of data from, the single-centre,
observational, cohort study, the Leipzig School Mesometrial Resection Study. Patients of any age with
stage IB1, IB2, IIA1, IIA2, or IIB cervical cancer (according to 2009 International Federation of
Gynecology and Obstetrics [FIGO]) had total mesometrial resection or extended mesometrial
resection and therapeutic lymph node dissection, done on the basis of ontogenetic cancer fields. We
defined sentinel node, first-line, second-line, and third-line lymph node regions as progressive
regional cancer fields. Primary outcomes were disease-specific survival and recurrence-free survival,
and treatment-related morbidity (assessed with the Franco-Italian glossary). Applying Cox
proportional hazard models, ontogenetic local (T) and regional (N) tumour staging was compared
with pathological T and N staging. This trial is registered with the German Clinical Trials Register,
number DRKS00015171.

Findings: Between Oct 16, 1999, and June 27, 2017, 523 patients were treated per protocol and
followed up for a median of 61·8 months (IQR 49·3-94·8). In 495 patients with cervical cancer treated
with cancer field surgery, 5-year disease-specific survival was 89·4% (95% CI 86·5-92·4) and
recurrence-free survival was 83·1% (79·7-86·6). In the per-protocol population of 523 patients,
treatment-related morbidity comprised 112 (21%) grade 2 and 15 (3%) grade 3 complications. The
most common moderate and severe treatment-related complications and sequelae were wound
dehiscence (17 [3%]), hydronephrosis (17 [3%]), bowel obstruction (26 [5%]), and lymph oedema (33
[6%]). One patient (<1%), who received total mesometrial resection, died from postoperative brain
infarction.

Interpretation: Total or extended mesometrial resection with therapeutic lymph node dissection
based on ontogenetic cancer fields results in good survival outcomes of patients with cervical cancer
in our institution, but needs to be investigated further in multicentre trials.

Funding: Leipzig School of Radical Pelvic Surgery, University of Leipzig Medical School, and the
Gynecologic Oncology Research Foundation.

https://pubmed.ncbi.nlm.nih.gov/31383547/ 1/2
2/27/23, 1:37 AM Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, o…

Copyright © 2019 Elsevier Ltd. All rights reserved.

Comment in
Radical surgery for cervical cancer.
Raspagliesi F, Bogani G.
Lancet Oncol. 2019 Sep;20(9):1198-1199. doi: 10.1016/S1470-2045(19)30409-7. Epub 2019 Aug 2.
PMID: 31383546 No abstract available.

Related information
MedGen

LinkOut - more resources


Full Text Sources
ClinicalKey
Elsevier Science

Medical
Genetic Alliance
International Agency for Research on Cancer - Screening Group
MedlinePlus Consumer Health Information
MedlinePlus Health Information

https://pubmed.ncbi.nlm.nih.gov/31383547/ 2/2

You might also like